2

SilcsBio, LLC Announces Release of CGenFF 2.0.0

SilcsBio, LLC Announces Release of CGenFF 2.0.0December 27, 2016Baltimore, MD, 15 November 2016 Version 2.0.0 is the second release of CGenFF program, extending support to a larger variety of drug-like molecules to be used routinely in Computer-Aided Drug Design projects. Specifically, it improves treatment of...

SilcsBio, LLC Receives Phase II NIH SBIR Funding

SilcsBio, LLC Receives Phase II NIH SBIR FundingAugust 8, 2016FOR IMMEDIATE RELEASE: July 7, 2016 Ken Malone SilcsBio, LLC 410.929.2305 Ken.Malone@silcsbio.com  SilcsBio, LLC Receives Phase II NIH SBIR Funding Baltimore, Maryland: SilcsBio, LLC announced today a $1.3 million funding award from the National...